SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings steep selloff is being tied mainly to fears that Kalshi and Polymarket are drawing wagering activity away from traditional sportsbooks and forcing costly investment in prediction markets. Traders disagree on whether that pressure will erode margins or whether DraftKings rapidly growing DKeX volume and legal challenges facing rivals could ultimately benefit the company.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, driven by stronger demand for Amtagvi, is the main catalyst behind the sharp rally, with analyst upgrades adding to bullish sentiment. Traders are also citing possible short covering and prospective lung-cancer data, while some warn about profit-taking and dilution risk.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The sharp selloff is tied to FHFA changes allowing VantageScore alongside FICO in mortgage pricing, raising concerns that competition could weaken FICOs longstanding mortgage-scoring advantage and pricing power. Traders are split between expecting further downside as the moat is reassessed and viewing the decline as an overreaction or oversold buying opportunity.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results beat expectations and lifted its full-year outlook, with record customer deposits and strong 2027 bookings pointing to resilient cruise demand; the news drove a sharp rally and lifted other cruise stocks. Bulls welcomed the results and stronger booking outlook, while bears pointed to fuel costs, margin pressure and weaker near-term guidance as risks.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

CEO C.J. Desais abrupt departure for Meta ahead of MongoDBs Investor Day has driven a sharp selloff and volatile trading, despite reaffirmed guidance and former CEO Dev Ittycheria returning as interim chief. Traders are split between viewing the leadership uncertainty as a lasting risk and seeing the selloff as overdone, with some pointing to Investor Day product updates and buyback plans as reasons for optimism.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are drawing attention for sharp volatility, with traders focused on upcoming insider share unlocks as a potential source of selling pressure. The debate pits that supply overhang and broader AI-stock weakness against optimism about Cerebras inference business and customer partnerships.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is drawing attention after a Bank of America upgrade tied to the potential for Google ad-tech remedies to improve independent exchanges access to advertising spend. Traders welcomed the upgrade and sharp rally, though some questioned whether the move can hold after similar rallies faded.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQures four-year AMT-130 Huntingtons data sparked a sharp selloff: disease-progression slowing on the cUHDRS measure fell to 44% from 80% at three years and was not statistically significant, raising concerns about durability. Traders debate whether that weakens the approval case or whether the BLA, based on the three-year data accepted by the FDA as its primary basis, remains intact; some also question the four-year comparison given patient dropouts and changes to the external control group.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Traders are tying QNTs sharp rally to its reported selection by The Clearing House for interoperability work on an on-chain money network for major banks, alongside broader interest in Quants financial-infrastructure partnerships. The community is divided over whether that adoption will translate into meaningful demand for the token, with some citing its limited supply and others warning that the partnerships token impact is unclear as volatility and profit-taking continue.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is drawing attention after closing a sizable stock-and-convertible-note financing, with traders blaming dilution and the offerings timing for the sharp selloff despite favorable VK2735 maintenance data. Some see the added capital as strengthening development and deal-making flexibility, while others criticize management; buyout and partnership talk remains speculative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


XORAA

Xora